VITL

VITL. com is a personalized nutrition company providing custom vitamin formulations and health testing services. It focuses on enhancing individual health outcomes through tailored solutions based on personal health assessments. Founded in 2015 and headquartered in London, UK, VITL.

com specializes in personalized nutrition solutions. The company was established by Jonathan Relph, who has previously founded other ventures. In October 2017, VITL raised GBP 0. 55 million in a Seed funding round led by ACF Investors, valuing the company at GBP 6.

84 million post-money. VITL. com specializes in personalized nutrition solutions, offering tailor-made vitamin formulations and at-home health tests, including DNA kits and blood tests. Their core product leverages an online consultation process that assesses individual health goals, dietary preferences, lifestyle habits, and genetic predispositions to deliver customized supplements.

These products aim to optimize health outcomes by addressing specific areas such as energy support, immune function, and skin health. Customers primarily include health-conscious individuals, and the company targets markets across Europe and the United States, providing its services through an e-commerce platform. VITL. com generates revenue through a subscription-based model, wherein customers receive monthly deliveries of personalized vitamins tailored to their ongoing health needs.

The company engages clients primarily through direct-to-consumer transactions, allowing for personalized service based on health assessments. Key products include the Vitamin & Cholesterol Blood Test at a price of USD 99. 95 and the DNA Nutrition Test at USD 180. 00, which contributes to predictable revenue streams as they cater to a growing client base focused on personalized health solutions.

VITL. com plans to leverage its recent Seed funding of GBP 0. 55 million, raised in October 2017, to support the development of new product offerings and to expand its market reach. Future initiatives include the launch of enhanced health testing kits and dietary supplements targeting specific health needs.

The company also aims to enter new markets across Europe and the United States by 2025, further broadening its customer base and enhancing its service offerings.